References of "Fecher-Bourgeois, Fabienne"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailEstimating the economic impact of a possible equine and human epidemic of West Nile virus infection in Belgium
Humblet, Marie-France ULg; Vandeputte, Sébastien; Fecher-Bourgeois, Fabienne ULg et al

in Eurosurveillance (2016), 21(31),

This study aimed at estimating, in a prospective scenario, the potential economic impact of a possible epidemic of WNV infection in Belgium, based on 2012 values for the equine and human health sectors ... [more ▼]

This study aimed at estimating, in a prospective scenario, the potential economic impact of a possible epidemic of WNV infection in Belgium, based on 2012 values for the equine and human health sectors, in order to increase preparedness and help decision-makers. Modelling of risk areas, based on the habitat suitable for Culex pipiens, the main vector of the virus, allowed us to determine equine and human populations at risk. Characteristics of the different clinical forms of the disease based on past epidemics in Europe allowed morbidity among horses and humans to be estimated. The main costs for the equine sector were vaccination and replacement value of dead or euthanised horses. The choice of the vaccination strategy would have important consequences in terms of cost. Vaccination of the country’s whole population of horses, based on a worst-case scenario, would cost more than EUR 30 million; for areas at risk, the cost would be around EUR 16–17 million. Regarding the impact on human health, short-term costs and socio-economic losses were estimated for patients who developed the neuroinvasive form of the disease, as no vaccine is available yet for humans. Hospital charges of around EUR 3,600 for a case of West Nile neuroinvasive disease and EUR 4,500 for a case of acute flaccid paralysis would be the major financial consequence of an epidemic of West Nile virus infection in humans in Belgium. [less ▲]

Detailed reference viewed: 16 (9 ULg)
Full Text
Peer Reviewed
See detailLa couverture santé universelle dans les pays à revenus faibles et intermédiaires : analyses économiques
Paul, Elisabeth ULg; Bodson, Oriane ULg; Ridde, Valéry et al

in Reflets et Perspectives de la Vie Economique (2016), 1

Les pays à revenu faible et intermédiaire sont confrontés à des besoins de financement élevés pour assurer une couverture santé universelle (CSU) permettant à chacun d'avoir accès à des services de santé ... [more ▼]

Les pays à revenu faible et intermédiaire sont confrontés à des besoins de financement élevés pour assurer une couverture santé universelle (CSU) permettant à chacun d'avoir accès à des services de santé de qualité sans encourir de difficultés financières. Cet article tente de montrer comment l'analyse économique peut être mobilisée pour identifier des stratégies utiles pour tendre vers la CSU. Trois axes complémentaires où l'analyse économique a une plus-value sont présentés : i) la mobilisation des ressources et l'équité verticale ; ii) l'amélioration de l'efficacité dans l'allocation des ressources et l'équité horizontale ; iii) la gestion opérationnelle des ressources, en particulier à travers le financement basé sur les résultats (efficience). Pour chacun, nous présentons un bref état des lieux de l'état des connaissances et évoquons quelques perspectives de recherche. [less ▲]

Detailed reference viewed: 45 (8 ULg)
Full Text
Peer Reviewed
See detailServing the general interest with public enterprises. New forms of governance and trends in ownership
Fecher-Bourgeois, Fabienne ULg; Bance, Philippe; Obermann, Gabriel

in Annals of Public and Cooperative Economics (2015), 86(4), 529-718

Detailed reference viewed: 18 (1 ULg)
Full Text
Peer Reviewed
See detailPresentation : Some current issues and challenges in the social economy
Fecher-Bourgeois, Fabienne ULg; Lévesque, Benoît

in Annals of Public and Cooperative Economics (2015), 86(2), 179-189

Detailed reference viewed: 41 (1 ULg)
Full Text
Peer Reviewed
See detailSome current issues and challenges in the social economy
Fecher-Bourgeois, Fabienne ULg; Lévesque, Benoît; Vallet, Nathalie

in Annals of Public and Cooperative Economics (2015), 86(2), 179-400

Detailed reference viewed: 24 (0 ULg)
Full Text
See detailLes inégalités en santé : diagnostics et remèdes
Fecher-Bourgeois, Fabienne ULg

Scientific conference (2015, May 30)

Detailed reference viewed: 23 (0 ULg)
Full Text
Peer Reviewed
See detailThe Production of Statistics for the Social Economy in Belgium: a focus on Mutuals and Cooperatives
Fecher-Bourgeois, Fabienne ULg; Ben Sedrine, Wafa ULg

in Bouchard, Marie; Rousselière, Damien (Eds.) The Weight of the Social Economy - An International Perspective (2015)

Detailed reference viewed: 41 (8 ULg)
Full Text
Peer Reviewed
See detailThe Governance of Mixed Companies: Policy Implications for Local Governments
Marra, A; Cruz, N.F.; Marques, R.C. et al

in Annals of Public and Cooperative Economics (2014), 85(1), 1-164

Detailed reference viewed: 97 (12 ULg)
Full Text
See detailPolitiques Sociales et de l'Emploi
Fecher-Bourgeois, Fabienne ULg

Learning material (2014)

Detailed reference viewed: 25 (4 ULg)
See detailUne comparaison internationale des systèmes de santé. A la recherche de l’efficacité et de l’équité
Fecher-Bourgeois, Fabienne ULg

Conference given outside the academic context (2013)

Detailed reference viewed: 22 (6 ULg)
Full Text
Peer Reviewed
See detailECONOMIC IMPACT OF USING AN ANTIVIRAL IN THE CONTROL OF A FOOT-AND-MOUTH DISEASE EPIZOOTIC IN SOUTHERN BELGIUM
Dal Pozzo, Fabiana ULg; Humblet, Marie-France ULg; Vandeputte, Sébastien ULg et al

Poster (2013, October)

Foot-and-mouth disease virus (FMDV) is a highly contagious pathogen of cloven-hoofed mammals and one of the biggest concerns for veterinary authorities. The control measures to be applied in case of an ... [more ▼]

Foot-and-mouth disease virus (FMDV) is a highly contagious pathogen of cloven-hoofed mammals and one of the biggest concerns for veterinary authorities. The control measures to be applied in case of an outbreak vary in function of the disease-free or disease-enzootic status. Vaccination depends on the prior identification of the involved viral serotype and subtype, it confers an immunity limited to 6 months and it requires between 4 to 7 days to trigger the immune response (i.e. immunity-gap). The use of anti-FMD drugs has been discussed as an alternative or supplementary method to be used in previously FMD-free countries/zones. Such an antiviral treatment could protect against the viral dissemination to fill the gap between vaccination and the rise of a protective immunity. Apart from broad spectrum antiviral agents, such as ribavirin, specific anti-FMDV molecules have been identified in vitro, but none of them has been used in clinical studies involving ruminants or pigs. Next to the anti-FMDV activity, the absence of toxicity and the withdrawal period influencing the food safety, the cost of the treatment would be another important parameter influencing the potential use of an antiviral agent in the control of a FMD outbreak. The aim of this study was to assess the economic impact of using an antiviral in the control of a FMD epizootic in southern Belgium (Walloon Region). This work was based on the results of previous investigations concerning the epidemiological and economic data of a FMD outbreak in Southern Belgium. In the considered scenario, the epizootic was caused by the introduction of an infected cow (during the incubation time) in a beef cattle farm during winter. During the two weeks between the brood cow introduction and the official declaration of the outbreak, animal movements occurred between other beef cattle farms. The economic effects of the epidemic were evaluated taking into account the air-borne transmission of FMDV, the occurrence of animal movements (two scenarios were considered, with a minimum of 2 and a maximum of 17 movements), the presence of bovine and small ruminant farms, as well as pig farms in the protection and surveillance zones around the initial and secondary outbreaks. The wild fauna was not involved in the epidemic. In order to integrate in the above scenario the application of an antiviral agent in the control of the disease, it was assumed that the efficacy of the anti-FMDV drug was proven by reducing viral excretion in infected animals as well as by preventing the infection in animals at risk. Two hypothetical prices were used to introduce in the model the costs related to the administration of the antiviral drug (5€ and 10€ per dose). Furthermore, different strategies of control could be envisaged, such as the administration of the drug to both domestic ruminants and pigs, or depending on the epidemiological role of these species in the FMD transmission and their density in the territory, the administration of the drug to only one of them. Other scenarios could be characterized by the use of the antiviral in the control of the epizootic within the protection and surveillance zones or in only one of them. The costs associated with the use of antivirals in the different proposed scenarios are compared to the costs and socio-economic losses associated with the FMD outbreak and the implementation of control measures. [less ▲]

Detailed reference viewed: 90 (3 ULg)
See detailEquité et efficacité du système belge de santé
Fecher-Bourgeois, Fabienne ULg

Scientific conference (2013, February 25)

Detailed reference viewed: 27 (11 ULg)
Full Text
See detailSEC95 approfondissement
Fecher-Bourgeois, Fabienne ULg

Learning material (2013)

Detailed reference viewed: 11 (1 ULg)